Consolidated Statements of Income - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Sales, net	$ 56,246	$ 63,559
Cost of sales	49,694	54,079
Gross profit	6,552	9,480
Selling and administrative expenses	3,807	3,696
Operating income	2,745	5,784
Other income (expense), net:
PPP Note forgiveness	0	1,659
Interest expense	(128)	(256)
Unrealized loss on investment in iBio Stock	(55)	(53)
Realized gains on sale of investment in iBio Stock	0	56
Other income	35	57
Total other income (expense), net	(148)	1,463
Income before income taxes	2,597	7,247
Income tax benefit, net	1,241	766
Net income	$ 3,838	$ 8,013
Basic net income per common share (in dollars per share)	$ 0.13	$ 0.27
Diluted net income per common share (in dollars per share)	$ 0.12	$ 0.25
Weighted average common shares outstanding - basic (in shares)	29,843,387	29,699,065
Add: Equivalent shares outstanding - stock options (in shares)	2,477,939	2,414,616
Weighted average common shares outstanding - diluted (in shares)	32,321,326	32,113,681